Sangeeta Bhorade to United States
This is a "connection" page, showing publications Sangeeta Bhorade has written about United States.
Connection Strength
0.208
-
Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation. Chest. 2013 Jun; 143(6):1717-1724.
Score: 0.048
-
Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection. J Heart Lung Transplant. 2008 Sep; 27(9):990-4.
Score: 0.034
-
Percepta Genomic Sequencing Classifier and decision-making in patients with high-risk lung nodules: a decision impact study. BMC Pulm Med. 2022 Jan 06; 22(1):26.
Score: 0.022
-
Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study. Chest. 2021 01; 159(1):401-412.
Score: 0.020
-
Report from the American Society of Transplantation on frailty in solid organ transplantation. Am J Transplant. 2019 04; 19(4):984-994.
Score: 0.018
-
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. Am J Respir Crit Care Med. 2018 01 15; 197(2):235-243.
Score: 0.016
-
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension. Ann Am Thorac Soc. 2017 Oct; 14(10):1514-1522.
Score: 0.016
-
Reliability of diagnostic criteria for bronchiolitis obliterans syndrome after lung transplantation: a survey. J Heart Lung Transplant. 2015 Jan; 34(1):65-74.
Score: 0.013
-
Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):527-34.
Score: 0.012
-
Obesity and primary graft dysfunction after lung transplantation: the Lung Transplant Outcomes Group Obesity Study. Am J Respir Crit Care Med. 2011 Nov 01; 184(9):1055-61.
Score: 0.011